Has been awarded the top position in three of G2 Software Review's Fall 2025 Pharma and Biotech Software category reports. kneat.com, inc. shares T.KSI are trading unchanged at $5.51.
Stocks in play: kneat.com, inc.
Baystreet.ca - Baystreet - Contributor Content
This article could contain syndicated content. We have not reviewed, approved, or endorsed the content and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here